Estrogen History Shapes Brain Risk
Postmenopausal women with type 2 diabetes face high dementia rates daily. Endogenous estrogen exposure might protect brains through decades. Diabetologists need reproductive history for risk talks. This study links fertility span to Alzheimer and vascular dementia directly. The study was published in the Diabetes Care.
Massive National Cohort Tracks Outcomes
Researchers identified 159,751 women over age 40 with type 2 diabetes from 2009 health exams. Mean age reached 64.5 plus or minus 8.0 years. Mean reproductive lifespan measured 33.6 plus or minus 4.5 years. Self-reported data captured parity and hormone replacement therapy use. National claims tracked dementia diagnoses and antidementia drugs.
Long Fertility Span Protects Most
Median follow-up lasted 8.3 years across the cohort. Total all-cause dementia cases hit 24,218 including 18,819 Alzheimer disease and 2,743 vascular dementia. Reproductive lifespan over 40 years versus under 30 showed hazard ratio 0.73 with 95% CI 0.69-0.78 for all dementia.
Parity and HRT Add Protection
Women with one birth had 27% lower all-cause dementia risk versus nulliparous women. Hormone replacement therapy over 5 years cut risk 17% compared to never users. Patterns held for both Alzheimer disease and vascular dementia subtypes.
Ask Menstrual History Routinely
Record age at menarche and menopause in all diabetic women over 50. Lifespan under 30 years flags highest brain risk. Counsel parity one as unexpectedly protective factor.
HRT Decisions Weigh Dementia Benefit
Long-term HRT use shows consistent dementia reduction in diabetes. Balance breast cancer risks against brain protection gains. Findings support personalized discussions beyond bone health.
Diabetes Clinics Need Brain Focus
Screen cognition yearly in short reproductive span diabetics. Early cholinesterase inhibitors might change trajectories. Estrogen history guides preventive priorities effectively.
Reproductive Metrics Beat Predictions
Fertility span outperforms many biomarkers for dementia risk in diabetes. Simple questions add prognostic power immediately.
Featured
Off
Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
- Study analyzed 159,751 postmenopausal women with T2D (mean age 64.5±8.0 years) from 2009 Korean health database with median 8.3-year follow-up identifying 24,218 dementia cases.
- Reproductive lifespan ≥40 years versus <30 years associated with 27% lower all-cause dementia risk (HR 0.73, 95% CI 0.69-0.78).
- Women with parity 1 showed 27% reduced risk of all-cause dementia compared to nulliparous women.
- Hormone replacement therapy use >5 years linked to 17% lower dementia risk versus non-users.
- Protective effects from long reproductive lifespan, parity 1, and prolonged HRT applied to both Alzheimer disease and vascular dementia in T2D women.
Source
Yu J, Cho JH, Han K, Park YMM, Lee SH. Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes. Diabetes Care. 2025;49(2):292-302. doi: https://doi.org/10.2337/dc25-1961
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
Korean study of 159,751 postmenopausal T2D women finds ≥40-year reproductive lifespan reduces dementia risk (HR 0.73), parity 1 lowers 27%, and HRT >5 years cuts 17% over 8.3 years.
User Segments
Release Date
Featured Order
0
Is Paid
0
Send Notification
Off